This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopw [2023/10/02 21:32] – [XopW] rkoebnik | bacteria:t3e:xopw [2025/07/24 22:53] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopW ====== | + | ====== |
Author: [[https:// | Author: [[https:// | ||
- | Internal reviewer: \\ | ||
- | Expert reviewer: **WANTED!** | ||
Class: XopW\\ | Class: XopW\\ | ||
Line 17: | Line 15: | ||
XopW was discovered via genome-wide screening for effector candidates in //X. oryzae// pv. //oryzae// (//Xoo//) strain MAFF 311018 in accordance with three criteria: i) ORF encoding proteins homologous to effectors of //P. syringae// strains and //X. campestris// | XopW was discovered via genome-wide screening for effector candidates in //X. oryzae// pv. //oryzae// (//Xoo//) strain MAFF 311018 in accordance with three criteria: i) ORF encoding proteins homologous to effectors of //P. syringae// strains and //X. campestris// | ||
+ | |||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | TT3S-dependent translocation of XopW has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). | + | TT3S-dependent translocation of XopW has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). |
=== Regulation === | === Regulation === | ||
Line 39: | Line 39: | ||
Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | ||
+ | |||
+ | Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL effectors in // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||
+ | |||